featured
Efficacy of Baxdrostat for Treatment-Resistant Hypertension
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
N. Engl. J. Med 2022 Nov 07;[EPub Ahead of Print], MW Freeman, YD Halvorsen, W Marshall, M Pater, J Isaacsohn, C Pearce, B Murphy, N Alp, A Srivastava, DL Bhatt, MJ BrownFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.